IL138606A - Solid, quick dissolving cetirizine formulations - Google Patents

Solid, quick dissolving cetirizine formulations

Info

Publication number
IL138606A
IL138606A IL13860699A IL13860699A IL138606A IL 138606 A IL138606 A IL 138606A IL 13860699 A IL13860699 A IL 13860699A IL 13860699 A IL13860699 A IL 13860699A IL 138606 A IL138606 A IL 138606A
Authority
IL
Israel
Prior art keywords
solid
quick dissolving
cetirizine formulations
dissolving cetirizine
formulations
Prior art date
Application number
IL13860699A
Other languages
English (en)
Other versions
IL138606A0 (en
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Publication of IL138606A0 publication Critical patent/IL138606A0/xx
Publication of IL138606A publication Critical patent/IL138606A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)
IL13860699A 1998-03-31 1999-03-20 Solid, quick dissolving cetirizine formulations IL138606A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
PCT/DE1999/000799 WO1999049843A1 (de) 1998-03-31 1999-03-20 Feste, schnellzerfallende cetirizin-formulierungen

Publications (2)

Publication Number Publication Date
IL138606A0 IL138606A0 (en) 2001-10-31
IL138606A true IL138606A (en) 2005-07-25

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13860699A IL138606A (en) 1998-03-31 1999-03-20 Solid, quick dissolving cetirizine formulations

Country Status (30)

Country Link
US (1) US6245353B1 (cs)
EP (1) EP1067904B1 (cs)
JP (1) JP2002509873A (cs)
KR (1) KR100653568B1 (cs)
CN (1) CN1136838C (cs)
AR (1) AR018828A1 (cs)
AT (1) ATE209899T1 (cs)
AU (1) AU750140B2 (cs)
BG (1) BG64741B1 (cs)
BR (1) BR9909233A (cs)
CA (1) CA2326809C (cs)
CY (1) CY1107331T1 (cs)
CZ (1) CZ300704B6 (cs)
DE (2) DE19814256A1 (cs)
DK (1) DK1067904T3 (cs)
ES (1) ES2168013T3 (cs)
HU (1) HU227477B1 (cs)
IL (1) IL138606A (cs)
NO (1) NO329071B1 (cs)
NZ (1) NZ506988A (cs)
PL (1) PL191266B1 (cs)
PT (1) PT1067904E (cs)
RU (1) RU2216318C2 (cs)
SI (1) SI1067904T1 (cs)
SK (1) SK284476B6 (cs)
TR (1) TR200002809T2 (cs)
TW (1) TWI233808B (cs)
UA (1) UA57615C2 (cs)
WO (1) WO1999049843A1 (cs)
ZA (1) ZA200005134B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3563070B2 (ja) 2000-07-17 2004-09-08 山之内製薬株式会社 経口吸収改善医薬組成物
CA2472396A1 (en) 2002-01-15 2003-07-24 Ucb Farchim, S.A. Formulations
CN100335041C (zh) * 2002-04-04 2007-09-05 辉瑞产品公司 美味咀嚼片剂
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
WO2005115345A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PL2377557T3 (pl) 2004-11-24 2017-05-31 Meda Pharmaceuticals Inc. Kompozycje zawierające azelastynę i sposoby ich zastosowania
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
JP2009517346A (ja) 2005-11-28 2009-04-30 イメイジノット ピーティーワイ エルティーディー 治療用化合物の経口送達系
AU2009288006B2 (en) * 2008-09-05 2014-07-17 Mcneil-Ppc, Inc. Method for making cetirizine tablets
EP2405747A4 (en) * 2009-03-13 2013-01-16 Nucitec Sa De Cv COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
WO2011146032A2 (en) * 2010-05-18 2011-11-24 Mahmut Bilgic Effervescent formulations
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
MX368363B (es) 2012-06-12 2019-09-30 Procter & Gamble Forma de dosificacion efervescente.
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
TWI732337B (zh) * 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) * 2017-11-15 2019-05-23 Berkeley Nox Limited Novel dietary supplements
ES2945809T3 (es) 2019-10-02 2023-07-07 Intas Pharmaceuticals Ltd Composiciones farmacéuticas sólidas efervescentes prácticamente sin sodio
JP7703137B2 (ja) * 2020-02-03 2025-07-07 ケンビュー・ブランズ・エルエルシー セチリジンを含む単層チュアブル錠剤
CN120437087A (zh) 2024-02-01 2025-08-08 科赴品牌有限责任公司 一种口腔溶解膜制剂、其用途及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
DE9190107U1 (de) * 1990-08-07 1993-12-16 Pfizer Inc., New York, N.Y. Abgabe-Vorrichtung mit durch Grenzflächen-Polymerisation erhaltenen Membranen
HU219242B (en) * 1991-05-13 2001-03-28 Boots Co Plc S(+)-ibuprofen sodium salt dihydrate, pharmaceutical composition comprising this compound and process for production of them
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
JPH08502288A (ja) * 1992-10-09 1996-03-12 ザ、プロクター、エンド、ギャンブル、カンパニー 感昌症状を治療するための医薬組成物及び用法
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
EP0624364B1 (de) * 1993-04-15 1996-07-24 Gerhard Dr. Gergely Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
EP0695175A1 (en) * 1993-04-30 1996-02-07 The Procter & Gamble Company Coated pharmaceutical compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
ZA200005134B (en) 2000-12-21
PL343199A1 (en) 2001-07-30
SK284476B6 (sk) 2005-04-01
BG104843A (en) 2001-07-31
CA2326809C (en) 2008-11-18
NZ506988A (en) 2002-05-31
RU2216318C2 (ru) 2003-11-20
US6245353B1 (en) 2001-06-12
JP2002509873A (ja) 2002-04-02
PL191266B1 (pl) 2006-04-28
DE19814256A1 (de) 1999-10-07
AR018828A1 (es) 2001-12-12
HUP0102676A2 (hu) 2001-11-28
NO20004722L (no) 2000-09-21
PT1067904E (pt) 2002-05-31
CN1295464A (zh) 2001-05-16
ATE209899T1 (de) 2001-12-15
CN1136838C (zh) 2004-02-04
IL138606A0 (en) 2001-10-31
CZ300704B6 (cs) 2009-07-22
EP1067904A1 (de) 2001-01-17
DK1067904T3 (da) 2002-04-02
AU3925399A (en) 1999-10-18
KR20010034718A (ko) 2001-04-25
BR9909233A (pt) 2000-11-28
SI1067904T1 (en) 2002-04-30
TR200002809T2 (tr) 2000-12-21
BG64741B1 (bg) 2006-02-28
EP1067904B1 (de) 2001-12-05
DE59900501D1 (de) 2002-01-17
CA2326809A1 (en) 1999-10-07
CZ20003481A3 (en) 2001-05-16
NO20004722D0 (no) 2000-09-21
NO329071B1 (no) 2010-08-16
SK14312000A3 (sk) 2001-07-10
HU227477B1 (en) 2011-07-28
HUP0102676A3 (en) 2002-12-28
TWI233808B (en) 2005-06-11
HK1036217A1 (en) 2001-12-28
AU750140B2 (en) 2002-07-11
KR100653568B1 (ko) 2006-12-05
ES2168013T3 (es) 2002-05-16
WO1999049843A1 (de) 1999-10-07
CY1107331T1 (el) 2012-12-19
UA57615C2 (uk) 2003-06-16

Similar Documents

Publication Publication Date Title
IL138606A0 (en) Solid, quick dissolving cetirizine formulations
ZA993338B (en) Pharmaceutical formulations.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
GB9804013D0 (en) Formulations
ZA992629B (en) (4-arylsulfonylamino)-tetrahydropyran-4-caboxylic acid hydroxamides.
ZA200108304B (en) Agrochemical formulations.
ZA200200477B (en) 2-pyrazolin-5-ones.
ZA200004956B (en) Vaccine composition.
ZA200005136B (en) Dihydropyrimides.
ZA997174B (en) Antiparasitic formulations.
GB0030757D0 (en) Equi-pressure geosteering
ZA200202537B (en) Pour-on-formulations.
ZA200201829B (en) New phenylpiperazines.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
MXPA01012478A (es) Formulaciones farmaceuticas mejoradas.
ZA200108968B (en) New compounds.
ZA200005510B (en) Pharmaceutical composition.
EG23909A (en) Vatamin d, analogs
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA9810637B (en) Formulations comprising dissolved paroxetine.
ZA993123B (en) Trisresorcinyltriazines.
ZA993473B (en) Pellet formulations.
ZA99890B (en) Pharmaceutical compositions.
ZA991761B (en) New agent.
ZA200204581B (en) Nitro-sulfobenzamides.

Legal Events

Date Code Title Description
HP Change in proprietorship
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees